Synteract Is A Full Service Contract Research Organizationcrofounded In 1995The Company Specializes In Supporting Pharmaceutical And Biotechnology Firms Throughout All Phases Of Drug Developmentit Has Established A Strong Reputationparticularly Among Emerging Biopharma Companiesby Offering Deep Therapeutic Expertise In Areas Such As Oncologyrare And Orphan Diseasesneurosciencedermatologyand Pediatrics The Company Provides Comprehensive Servicesincluding Conducting Clinical Trials And Managing Studies Across Multiple Continentswith Nearly 4 000 Studies Completed In Over 62 Countriessynteract Demonstrates Significant Global Reach And Operational Capabilitiesits Client Base Primarily Includes Pre Revenue Biotech And Pharmaceutical Companiesand It Collaborates With Drug Developerspatientsinvestigatorsand Regulatory Experts To Facilitate The Development Of New Therapies And Treatmentsin December 2020Synteract Was Acquired By Syneos Healthenhancing Its Position In The Biopharmaceutical Industry
